National Center for Tuberculosis and Lung Diseases, Georgia Report issue

Government Phase 2 Phase 3

Organization Overview

First Clinical Trial
2016
NCT02781909
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

National Center for Tuberculosis and Lung Diseases (NCTLD) | National Center for Tuberculosis and Lung Diseases of Georgia (NCTLD) | National Center for Tuberculosis and Lung Disease, Tbilisi, Georgia